MESOBLAST LIMITED

2.33%

$2.52

Market Cap $3.225B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Latest Threads

Tag

Subject

MSB

Mesoblast 2025: The year of acting like a publicly listed company

21 22 23

13:19

1.3K

516K

13:19

Last post Pledge

1.3K

516K

MSB

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

4 5 6

11:57

343

139K

11:57

Last post nippy

343

139K

MSB

Cell Therapy News/Articles

330 331 332

10:21

19K

8.3M

10:21

Last post JDBL

19K

8.3M

MSB

NASDAQ Meso daily flow charts

3 4 5

06:12

280

117K

06:12

Last post LearningEachDay

280

117K

MSB

Ann: Ceasing to be a substantial holder

25/07/25

3.2K

25/07/25

Last post stevo1963

3.2K

MSB

MSB Shorts

4 5 6

25/07/25

358

117K

25/07/25

Last post ssm73

358

117K

MSB Biotech

MSB - a new dawn

36 37 38

25/07/25

2.2K

951K

25/07/25

Last post pld89

2.2K

951K

MSB

Ann: Ceasing to be a substantial holder

25/07/25

3.4K

25/07/25

Last post stocksa

3.4K

See All Discussions

Timeline

Ceasing to be a substantial holder
25 Jul 18:50	Share

Ceasing to be a substantial holder
25 Jul 08:17	Share

Becoming a substantial holder
23 Jul 08:14	Share

Ceasing to be a substantial holder
21 Jul 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
18 Jul 09:58	Share

Becoming a substantial holder
18 Jul 08:20	Share

Notification of cessation of securities - MSB
14 Jul 18:23	Share

Notification regarding unquoted securities - MSB
14 Jul 18:19	Share

Application for quotation of securities - MSB
14 Jul 18:14	Share

Notification regarding unquoted securities - MSB
14 Jul 18:08	Share

Ceasing to be a substantial holder
08 Jul 18:46	Share

Becoming a substantial holder
07 Jul 08:20	Share

Mesoblast and FDA Align on Key Items for Revascor BLA
01 Jul 09:49	Share

Ceasing to be a substantial holder
26 Jun 08:21	Share

Ceasing to be a substantial holder
18 Jun 08:19	Share

Becoming a substantial holder
17 Jun 08:23	Share

Ceasing to be a substantial holder
16 Jun 08:19	Share

Mesoblast Maintains Momentum with FDA
12 Jun 10:14	Share

Becoming a substantial holder
06 Jun 08:21	Share

Becoming a substantial holder
05 Jun 08:18	Share

Becoming a substantial holder
03 Jun 15:59	Share

Ceasing to be a substantial holder
03 Jun 08:21	Share

FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
15 May 10:01	Share

Becoming a substantial holder
14 May 08:18	Share

Ceasing to be a substantial holder
09 May 08:24	Share

Becoming a substantial holder
08 May 08:20	Share

Ceasing to be a substantial holder
07 May 15:26	Share

Becoming a substantial holder
02 May 14:07	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:13	Share

Initial Director's Interest Notice
29 Apr 09:37	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.52		Change -0.060(2.33%)		Mkt cap ! $3.225B

Open	High	Low	Value	Volume
$2.58	$2.61	$2.50	$12.63M	4.955M

Buyers (Bids)

No.	Vol.	Price($)
1	8366	$2.51

Sellers (Offers)

Price($)	Vol.	No.
$2.53	8780	4

View Market Depth

No.	Vol.	Price($)
1	8366	2.510
1	3577	2.500
1	1204	2.490
2	8430	2.470
1	22300	2.460

Price($)	Vol.	No.
2.530	1289	2
2.540	3800	1
2.550	20000	1
2.580	40000	1
2.590	18880	2

Last trade - 16.10pm 25/07/2025 (20 minute delay)

MSB (ASX) Chart

MESOBLAST LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Mesoblast (ASX:MSB) flags strengthened heart function in latest trial results

28 Feb 2023 10:07 (AEDT)

Latest Articles

The market shrugged at Mesoblast's latest FDA win. Is it just another Droneshield?

Mesoblast (ASX:MSB) has revealed the US FDA has given its flagship drug a 7 year exclusivity period, blocking...

Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab

Mesoblast (ASX:MSB) has seen shares fall just shy of -3% heading into lunchtime trades despite apparent tariff relief.

Mesoblast kicks off treatment for first 3 kids with graft-host disease. So why are shares down?

otCopper favourite Mesoblast (ASX:MSB) has announced it's begun treating the first 3 children with skin graft-versus-host disease in the US, at the same time the company received medicare (US) and medicaid coverage.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News